Obesity Impaired CAR-T Cell Antitumor Activity
New laboratory research linked obesity-associated inflammation to reduced T cell effectiveness in breast cancer models.
Updated on Sept. 29, 2026 in Weight Loss
Live Poll
Does learning about how obesity impacts cancer treatment outcomes change your approach to health?
Recent laboratory experiments demonstrated that obesity hampers the efficacy of B7-H3.CAR-T cells in treating triple-negative breast cancer. The study highlights how systemic inflammation impacts the durability of immune-based cancer responses.
Why it matters
Understanding how obesity alters the immune landscape provides crucial insight into why certain patients may have diminished responses to advanced cellular therapies. This discovery emphasizes the intersection between metabolic health and the success of adaptive immune interventions.
Laboratory findings show obesity-associated cytokines upregulate B7-H3 expression in human and murine triple-negative breast cancer cells. Research confirms B7-H3 expression is a requirement for obesity to drive tumor growth in vivo.
The details
Obesity induces chronic inflammatory states that result in significant transcriptomic changes and reduced glycolytic capacity in T cells. These metabolic shifts ultimately weaken the ability of CAR-T cells to provide a durable antitumor response.
Timeline
September 29, 2026: The research findings were published.
The Big Picture
This research updates our understanding of the metabolic barriers faced by the National Cancer Institute's CAR-T cell immunotherapy program. It identifies obesity as a significant hurdle that must be accounted for to optimize clinical success in next-generation cancer treatments.
This study highlights the need for clinicians to consider metabolic health when evaluating candidates for advanced cellular immunotherapies. It may lead to future screening protocols that assess inflammatory markers to better predict treatment durability.
The takeaway
Maintaining metabolic health may be essential for optimizing the body's response to advanced cancer treatments. Future clinical strategies will likely need to address systemic inflammation to preserve the effectiveness of T cell-based therapies.
Further reading
Learn more about the latest research in our Weight Loss section.
Source note: This article includes information reported by Nature.
Live Poll
Does learning about how obesity impacts cancer treatment outcomes change your approach to health?
